Oak Street Health Inc (OSH)
US67181A1079 - Common Stock
Taking everything into account, OSH scores 2 out of 10 in our fundamental rating. OSH was compared to 118 industry peers in the Health Care Providers & Services industry. OSH may be in some trouble as it scores bad on both profitability and health. OSH is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year OSH has reported negative net income.
In the past year OSH has reported a negative cash flow from operations.
In the past 5 years OSH always reported negative net income.
In the past 5 years OSH always reported negative operating cash flow.
1.2 Ratios
The profitability ratios for OSH are negative, so there is not much use analyzing them.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
OSH has a worse Gross Margin (3.61%) than 80.00% of its industry peers.
In the last couple of years the Gross Margin of OSH has declined.
OSH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 3.61% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.28%
GM growth 5Y-35.39%
2. Health
2.1 Basic Checks
OSH does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OSH has been increased compared to 1 year ago.
Compared to 5 years ago, OSH has more shares outstanding
Compared to 1 year ago, OSH has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 1.98 indicates that OSH is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.98, OSH is in line with its industry, outperforming 58.26% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.98 |
ROIC/WACCN/A
WACC7.66%
2.3 Liquidity
A Current Ratio of 1.41 indicates that OSH should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.41, OSH is in line with its industry, outperforming 50.43% of the companies in the same industry.
OSH has a Quick Ratio of 1.41. This is a normal value and indicates that OSH is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of OSH (1.41) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.41 | ||
| Quick Ratio | 1.41 |
3. Growth
3.1 Past
OSH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -20.11%.
Looking at the last year, OSH shows a very strong growth in Revenue. The Revenue has grown by 50.84%.
Measured over the past years, OSH shows a very strong growth in Revenue. The Revenue has been growing by 63.49% on average per year.
EPS 1Y (TTM)-20.11%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q9.68%
Revenue 1Y (TTM)50.84%
Revenue growth 3Y57.17%
Revenue growth 5Y63.49%
Revenue growth Q2Q46.59%
3.2 Future
Based on estimates for the next years, OSH will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.84% on average per year.
OSH is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 32.73% yearly.
EPS Next Y27.65%
EPS Next 2Y22.71%
EPS Next 3Y20.89%
EPS Next 5Y18.84%
Revenue Next Year42.14%
Revenue Next 2Y39.41%
Revenue Next 3Y36.49%
Revenue Next 5Y32.73%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for OSH. In the last year negative earnings were reported.
Also next year OSH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as OSH's earnings are expected to grow with 20.89% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.71%
EPS Next 3Y20.89%
5. Dividend
5.1 Amount
No dividends for OSH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Oak Street Health Inc
NYSE:OSH (5/1/2023, 7:04:01 PM)
After market: 38.98 -0.02 (-0.05%)39
+0.03 (+0.08%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap9.52B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 3.61% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.05
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.41 | ||
| Quick Ratio | 1.41 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-20.11%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y27.65%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)50.84%
Revenue growth 3Y57.17%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y